Eton Pharmaceuticals, Inc. (ETON) vs Phibro Animal Health Corporation (PAHC)
A side-by-side comparison of Eton Pharmaceuticals, Inc. and Phibro Animal Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ETON
Eton Pharmaceuticals, Inc.
$55.42HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
PAHC
Phibro Animal Health Corporation
$37.30HealthcareDelayed quote: Oct 6, 2026, 11:45 AM EDT
Total return — ETON vs PAHC
growth of $100 · dividends reinvested · last 8yETON +789.9% (+31.4%/yr)PAHC +24.8% (+2.8%/yr)ETON compounded faster over this window
Log scale — wide-divergence pair
ETON PAHC
ETON vs PAHC: by the numbers
- •ETON is the larger company ($1.52B vs $1.51B market cap).
- •PAHC trades at the lower trailing earnings multiple (15.29 vs 144.10 P/E), one valuation lens rather than an overall verdict.
- •ETON converts more revenue to profit (12.02% vs 6.57% net margin).
- •ETON grew revenue faster over the past five years (47.98% vs 12.75% CAGR).
- •PAHC pays a dividend (1.29% yield), while ETON has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | ETON | PAHC |
|---|---|---|
| P/E ratio | 144.10 | 15.29 |
| Forward P/E | 50.96 | 10.66 |
| PEG ratio | N/A | 1.20 |
| P/S ratio | 14.38 | 1.00 |
| P/B ratio | 32.59 | 3.92 |
| EV / EBITDA | 72.91 | 8.96 |
| FCF yield | 0.97% | 0.65% |
Profitability
| Metric | ETON | PAHC |
|---|---|---|
| Gross margin | 57.87% | 33.71% |
| Operating margin | 0.09% | 13.07% |
| Net margin | 12.02% | 6.57% |
| ROE | 27.24% | 25.87% |
| ROIC | 20.41% | 11.91% |
Dividends
| Metric | ETON | PAHC |
|---|---|---|
| Dividend yield | N/A | 1.29% |
| Payout ratio | N/A | 19.67% |
Growth (annualized)
| Metric | ETON | PAHC |
|---|---|---|
| Revenue CAGR (5Y) | 47.98% | 12.75% |
| EPS CAGR (5Y) | N/A | 12.92% |
| FCF CAGR (5Y) | N/A | -12.27% |
| Total return CAGR (5Y) | 63.04% | 14.40% |
Frequently asked
- Which has the lower trailing P/E, ETON or PAHC?
- PAHC has the lower trailing P/E: ETON trades at 144.10 and PAHC at 15.29. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, ETON or PAHC?
- Over the past five years, ETON grew revenue faster — ETON at a 47.98% CAGR versus PAHC at 12.75%.
- Does ETON or PAHC pay a bigger dividend?
- PAHC pays a dividend (1.29% yield), while ETON has no payments in the available dividend history.
- Is ETON or PAHC more profitable?
- ETON runs the higher net margin — ETON at 12.02% versus PAHC at 6.57%.
- How have ETON and PAHC total returns compared?
- Over the past 5 years, ETON delivered 63.04% and PAHC delivered 14.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Eton Pharmaceuticals P/E ratioPhibro Animal Health P/E ratioPhibro Animal Health dividend yieldEton Pharmaceuticals ROEPhibro Animal Health ROEEton Pharmaceuticals operating marginPhibro Animal Health operating marginEton Pharmaceuticals revenue growthPhibro Animal Health revenue growthEton Pharmaceuticals free cash flowPhibro Animal Health free cash flow
Eton Pharmaceuticals & Phibro Animal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.